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 32 
Abstract 33 
Background: Alcohol use disorders are associated with single nucleotide polymorphisms 34 
in GABRA2, the gene encoding the GABAA receptor α2-subunit in humans.  Deficient 35 
GABAergic functioning is linked to impulse control disorders, intermittent explosive disorder, 36 
and to drug abuse and dependence, yet it remains unclear if α2-containing GABAA receptor 37 
sensitivity to endogenous ligands is involved in excessive alcohol drinking.     38 
Methods: Male wild-type C57BL/6J and point-mutated mice rendered insensitive to 39 
GABAergic modulation by benzodiazepines (H101R), allopregnanolone or THDOC (Q241M), 40 
or high concentrations of ethanol (S270H/L277A) at α2-containing GABAA receptors were 41 
assessed for their binge-like, moderate or dependence-inducing drinking using drinking in the 42 
dark, continuous access and intermittent access to alcohol protocols, respectively.  Social 43 
approach by mutant and wild-type mice in withdrawal from intermittent access to alcohol was 44 
compared to approach by water-drinking controls.   Social deficits in withdrawal were treated 45 
with allopregnanolone (0, 3.0, 10.0 mg/kg, i.p.) or midazolam (0, 0.56, 1.0 mg/kg, i.p.).   46 
Results: Mice with benzodiazepine-insensitive α2-containing GABAA receptors (H101R) 47 
escalated their binge-like drinking. Mutants harboring the Q241M point-substitution in Gabra2 48 
showed blunted chronic intake in the continuous and intermittent access protocols.  49 
S270H/L277A mutants consumed excessive amounts of alcohol but, unlike wild-types, they did 50 
not show withdrawal-induced social deficits. 51 
Conclusions: These findings suggest a role for: 1.) H101 for species-typical binge-like 52 
drinking, 2.) Q241 for escalated dependence-inducing drinking, and 3.) S270 and/or L277 for the 53 
development of withdrawal-associated social deficits.   Clinical findings report reduced BZD-54 
binding sites in the cortex of dependent patients; the present findings suggest a specific role for 55 
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BZD-sensitive α2-containing receptors.  In addition, amino acid residue 241 in Gabra2 is 56 
necessary for positive modulation and activation of GABAA receptors by allopregnanolone and 57 
THDOC; we postulate that neurosteroid action on α2-containing receptor may be necessary for 58 
escalated chronic ethanol intake.  59 
 60 
Key words: Gabra2, alcohol use disorder, binge-like drinking, alcohol withdrawal, chronic 61 
alcohol drinking 62 
 63 
 64 
  65 
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More than half of American adults consume alcohol at least once a year; yet, only 7% of 66 
the population will receive a diagnosis of an alcohol use disorder (AUD). Deficits in inhibitory 67 
transmission, particularly in the prefrontal cortex, may increase the risk of developing an AUD 68 
and have been linked to impulse control disorders, intermittent explosive disorder, and to drug 69 
abuse and dependence (Volkow et al., 1993; Best et al., 2002; Coccaro et al., 2007; Davidson et 70 
al., 2000; Heinz et al., 2011).  Within the central nervous system, fast synaptic inhibition is 71 
mediated, in part, by GABAA receptors comprised of 2α, 2β, and 1γ subunits surrounding a 72 
ligand-gated chloride ion channel (Olsen and Sieghart 2008).  Heterogeneity in GABAA receptor 73 
composition can determine sensitivity to endogenous and exogenous receptor modulators 74 
including benzodiazepines, neurosteroids, ethanol and general anesthetics (Belelli and Lambert 75 
2005; Farrant and Nusser 2005; Olsen and Sieghart 2008).  76 
Numerous human genetics studies identify a link between alcohol dependence and single-77 
nucleotide polymorphisms (SNPs) in GABRA2, the gene encoding the GABAA receptor α2-78 
subunit protein (Covault et al., 2004; Edenberg et al., 2004; Bierut et al., 2010; Li et al., 2014).  79 
Minor allelic variants of these SNPs appear to be inherited together within haplotype blocks in 80 
the GABRA2 gene (Covault et al., 2004; Fehr et al., 2006; Enoch et al., 2009).   Guided by 81 
research on the association between allelic variants in the human genome and alcohol 82 
dependence, the present work employs preclinical genetic mouse models to clarify whether 83 
alterations in α2-containing GABAA receptor sensitivity to alcohol, select neurosteroids, or to 84 
benzodiazepines may play a functional role in escalating binge-like or dependence-inducing 85 
alcohol consumption.   86 
A major limitation in the field of alcohol research is the enigmatic site of action for 87 
clinically relevant doses of alcohol. Using in vitro techniques, studies have identified the α4βδ or 88 
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α6βδ GABAA subtypes for potentiation of inhibitory currents by low, physiologically relevant 89 
concentrations of alcohol: yet, to date, there is no universal agreement on these findings (Suzdak 90 
et al., 1986; Mehta and Ticku 1988; Sundstrom-Poromaa et al., 2002; Wallner et al., 2003; 91 
Borghese et al., 2006a; but White et al., 1990; Mihic et al., 1994; Homanics et al., 1997; 92 
Borghese and Harris 2007).  A second approach is to use rodent models of voluntary alcohol 93 
consumption to evaluate the behavior of mice harboring targeted mutations. Although behavior 94 
is far-removed from the possible receptor site of action, in the absence of selective 95 
pharmacological tools, behavioral studies can reveal which receptor domains may be necessary 96 
for non-selective drugs like alcohol to elicit specific behavioral effects. 97 
By introducing targeted point-substitutions in the α2-subunit protein sequence, three 98 
mutant mouse strains have been generated with α2-containing GABAA receptors that are 99 
insensitive to modulation by benzodiazepines (in vitro: Wieland et al., 1992; Benson et al., 1998; 100 
in vivo: Low et al., 2000), modulation and activation by allopregnanolone and 101 
tetrahydrodeoxycorticosterone (in vitro: Hosie et al., 2006, 2009), or modulation by high 102 
concentrations of ethanol (in vitro: Mihic et al., 1997; Borghese et al., 2006b; in vivo: Homanics 103 
et al., 2005; Blednov et al., 2011; Werner et al., 2011).  Assessing these mutant mice for binge-104 
like, moderate and dependence-inducing alcohol consumption may clarify the relationship 105 
between α2-containing GABAA receptor sensitivity to positive modulators and escalated alcohol 106 
consumption.   107 
Methods 108 
Animals 109 
Mutant H101R mice were homozygous for a histidine to arginine point-substitution in 110 
Gabra2, conferring insensitivity to benzodiazepines at α2-containing GABAA receptors.  H101R 111 
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mutants were initially backcrossed for fifteen generations to a wild-type C57BL/6J (WT; Jackson 112 
Laboratories, Bar Harbor, ME) background to establish a line that is congenic with WT mice.  113 
Therefore, experimental H101R mutants and WT mice were generated from filial homozygous 114 
breeding pairs.   115 
Experimental mutant S270H/L277A mice were homozygous for a serine to histidine 116 
mutation and a gain-of-function leucine to alanine point-substitution in Gabra2, rendering them 117 
insensitive to some effects of ethanol while maintaining near-normal GABA-responding (Werner 118 
et al., 2011).  Mutant S270H/L277A mice were bred to a C57BL/6J background for at least six 119 
generations at Jackson Laboratories (stock number: 012942), and for two generations in the Tufts 120 
Psychopharmacology lab (Medford, MA). Experimental neurosteroid-insensitive Q241M 121 
mutants, bred to a C57BL/6J background, were homozygous for a glutamine to methionine 122 
point-substitution in Gabra2.  Homozygous S270H/L277A and Q241M point-mutants and their 123 
WT counterparts were bred from heterozygous pairs.  Tail samples were collected for genotyping 124 
by PCR (Transnetyx, Inc.). Data analyses revealed no differences between ethanol consumption 125 
by WT mice generated from heterozygous crosses and WT mice bred from homozygous pairs; 126 
therefore all WT groups were collapsed for subsequent analyses and for data portrayal. See 127 
Table 1 for all experimental group ns.  128 
At eight-to-ten weeks, experimental mutant and WT males were housed singly to assess 129 
individual alcohol or tastant solution intake.  Adult wild-type female C57BL/6J mice (n=20) 130 
were ovariectomized (OVX) and used as social stimulus mice for social approach testing during 131 
withdrawal from alcohol.  All mice were housed in clear polycarbonate cages (28x17x14 cm) 132 
lined with pine shavings within a temperature-controlled mouse vivarium (21±1 ºC, 30-40% 133 
humidity) that was kept on a 12-h photocycle (lights off 0700h).  Experimental males and OVX 134 
Gabra2 AND BINGE VERSUS CHRONIC EXCESSIVE ETOH INTAKE  7 
 
mice received unrestricted access to rodent chow (Purina LabDiet 5001, PMI Nutrition 135 
International, Brentwood, MO). With the exception of males assigned to the drinking in the dark 136 
protocol, mice received continuous access to tap water. During assessments of fluid intake, 137 
solutions were presented in 50 mL centrifuge tubes (Nalgene). Each centrifuge tube was fitted 138 
with a rubber stopper (No. 5, Fisher Scientific, Agawam, MA) and a sipper-tube containing two 139 
ball bearings (Ancare Corp., Bellmore, NY) to prevent unintentional fluid loss. All animals were 140 
cared for in accordance with the National Research Council’s Guide for the Care and Use of 141 
Laboratory Animals (8th ed., 2011) and protocols were approved by the Institutional Animal Care 142 
and Use Committee of Tufts University.  143 
 144 
Binge-like drinking: Drinking in the dark 145 
Adult mutant H101R, S270H/L277A, Q241M and WT males were assessed for binge-146 
like ethanol intake in their home cages according to the four-day, drinking in the dark (DID) 147 
procedure outlined by Rhodes et al., (2005). Three hours into the dark photoperiod, water bottles 148 
were replaced with a single 50 mL centrifuge tube containing 20% EtOH (w/v). On days 1-3, 149 
mice received 2-hr access to 20% EtOH after which EtOH was replaced with water for the 150 
remaining 22-hr. On day 4, binge-like intake was measured over the course of an extended, four-151 
hr access period.  Blood samples were then promptly collected from the submandibular vein, 152 
centrifuged at 4ºC and plasma (5 μL) was analyzed for blood ethanol concentration (BEC) using 153 
the AM-1 Analox Analyzer (Analox Instruments USA; Lunenburg, MA).  Binge-like drinking 154 
was operationally defined as a pattern of alcohol consumption resulting in a BEC exceeding 80 155 
mg/dL within 4 h.  156 
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In an adaptation of the DID protocol, H101R, S270H/L277A, Q241M and WT males 157 
were evaluated for their pattern of 20% EtOH binge-like intake using a contact lickometer setup. 158 
Each experimental male’s home cage was fitted with a custom-made stainless steel panel; sipper-159 
tubes were lowered through a hole in the right side of each panel for fluid presentation. Stainless 160 
steel mesh flooring was secured to the bottom of each panel to form a raised platform. To drink, 161 
mice stood on this mesh platform and made tongue-contact with the metal sipper-tube, thereby 162 
closing a circuit. The mesh platform and sipper-tube were each connected to a contact lickometer 163 
controller (MedAssociates; model ENV-250B) which transmitted signals to a MED-PC interface; 164 
a lick was recorded each time a closed circuit was detected (detection threshold: >0.001 ms 165 
interlick interval).  All mice were habituated to the lickometer setup for three days with free 166 
access to tap water and rodent chow prior to the four-day DID procedure.  Blood was collected 167 
immediately after 4-hour access to 20% EtOH on the fourth day of the DID protocol for BEC 168 
analysis.   169 
In a second adaptation of DID, we aimed to determine if escalated binge-like drinking in 170 
the classic protocol was due to involuntary alcohol intake in the absence of water.  According to 171 
this adaptation, mice had access to two centrifuge tubes of water for 22h or 20h per day. For the 172 
first three days, one water tube was exchanged with 20% EtOH, signifying the beginning of the 173 
two-hour, two-bottle choice access period. On the final, binge day, mice received four-hour 174 
access to water and 20% EtOH.  Because only H101R mutants escalated their binge-like 175 
drinking in the one-bottle DID test, only these mutants and WT mice were assessed in this 176 
protocol.   177 
For all drinking experiments, mice were weighed daily and centrifuge tubes were 178 
weighed prior to and after the EtOH or tastant access period to determine intake volume (mL; 179 
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assuming 1g=1mL).  Alcohol consumption was calculated as grams of EtOH consumed 180 
according to body weight (g/kg) and as percent preference. To control for unintentional fluid 181 
loss, bottle measurements were recorded from an empty cage. These values were subtracted from 182 
each mouse’s mL intake to account for leakage during the fluid access period.  183 
 184 
Intermittent and continuous access to ethanol 185 
Eight-to-ten-week old mutant H101R, S270H/L277A, Q241M and WT males were 186 
assessed for dependence-inducing, voluntary ethanol consumption according to the intermittent 187 
access procedure as explained previously by Hwa et al., (2015).  In short, three hours into the 188 
dark phase on Mondays, Wednesdays and Fridays, mice received two-bottle choice, 24-hr access 189 
to tap water and 20% EtOH. On all other days, mice were presented with two centrifuge tubes 190 
filled with tap water.  To control for side-preference, EtOH presentation alternated between the 191 
right and left side of the cage lid.  This intermittent schedule of alcohol presentation has been 192 
shown to induce escalated EtOH consumption by C57BL/6J WT males (20-25 g/kg/24h; Hwa et 193 
al., 2011).  To contrast with the escalated levels of alcohol intake observed using the intermittent 194 
access procedure, separate adult mutant and WT males either received continuous access to 20% 195 
EtOH and water for six weeks (Fig S1).   196 
 197 
Ascending concentrations of ethanol, sucrose or quinine 198 
Ascending concentrations of EtOH (3, 6, 10, 20% w/v) and water were presented to adult 199 
male mutant and WT mice. Each concentration was made available for four consecutive days 200 
with presentation alternating sides daily (3% EtOH and water on days 1-4, 6% on days 5-8, 10% 201 
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on days 9-12, and 20% on days 13-16). Four-day individual intake averages were calculated for 202 
each concentration to account for any side preference.  203 
To determine if preference for palatable and aversive tastants differed between mutant 204 
lines, male mutant and wild-type mice were tested for their sucrose (10, 30, 100 mM) and 205 
quinine (0.1, 0.3 mM) intake.  Ascending concentrations of the tastant solution and water were 206 
presented for four days per concentration as detailed for EtOH above.  After the final day of 207 
access to the highest concentration of sucrose, mice received two weeks of water prior to 208 
receiving the lowest concentration of quinine.   209 
 210 
Social approach in forced alcohol abstinence  211 
Alcohol withdrawal severity was assessed as an indicator of dependent-like behavior in 212 
chronic, alcohol –drinking mice.  To do this, we chose to measure deficits in social approach 213 
(Knapp et al., 2005; Newman et al., 2015) and defined alcohol dependence as a pattern of 214 
drinking that produced withdrawal symptoms in the form of reduced social approach behavior by 215 
mice in forced ethanol abstinence as compared to ethanol-naïve, genotype-matched controls (Fig 216 
S1, S2).  217 
Male mutant and WT mice either received intermittent access to 20% EtOH or access to 218 
two bottles of tap water for 16 consecutive weeks (Fig S1).  During week seven, mice were 219 
habituated to intraperitoneal (i.p.) injections and were evaluated for side preference in a three-220 
chamber apparatus.  During side preference screens, the male mouse was placed in the center 221 
chamber of the three-chamber apparatus; after a 5-min habituation, the two side doors were 222 
opened and the mouse was permitted to explore all three chambers for 10-min.  Two ethanol-223 
drinking experimental mice (one WT, one H101R) and two EtOH-naïve control mice (one 224 
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H101R, one Q241M) were excluded from subsequent social approach testing because they 225 
showed a >60% side preference in the absence of a social stimulus animal  during  these 15-min 226 
screening sessions (Table 1).  227 
From weeks eight to sixteen, mice were tested weekly for social approach toward a novel 228 
OVX stimulus mouse six-to-eight hours after 20% EtOH was replaced with water for EtOH-229 
drinking animals.  During social approach testing, the male experimental or control mouse was 230 
first held within the central chamber of a three-chamber apparatus for a 5-min habituation period 231 
(Fig S2).  Males were randomly assigned a novel OVX female each social approach test day and 232 
no two males received the same female stimulus animal on the same day.  As the male habituated 233 
to the central chamber, his assigned OVX stimulus mouse was placed in a wire mesh cage in 234 
either the right or left chamber.  Following habituation, the male received an injection and was 235 
returned to the central chamber. Thirteen minutes later, the doors on either side of the central 236 
chamber were lifted, allowing the male to move freely between the central chamber, the chamber 237 
with the OVX stimulus mouse, and a third chamber with an empty stimulus cage during a 10-238 
min social approach test.  EthoVision XT software tracked the male and recorded his total 239 
distance travelled (cm) and the duration of time he spent within the social approach zone.  The 240 
social approach zone was defined as the region extending 2.25 cm past the radius of the occupied 241 
stimulus cage.   242 
For the initial social approach test, ethanol-drinking experimental males in forced 243 
abstinence and ethanol-naïve controls were treated systemically with vehicle (half received 20% 244 
βCD, half received 0.9% saline).  To establish which genotypes demonstrated social deficits in 245 
withdrawal, two-way analyses of variance (ANOVA) were conducted within each genotype 246 
(Forced EtOH abstinence vs. EtOH-naïve; saline vs. 20% BCD vehicle on the first day). 247 
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To treat alcohol withdrawal symptoms and recover social approach behavior, mice were 248 
tested weekly in the three-chamber apparatus following intraperitoneal injections of midazolam 249 
(0, 0.56, 1.0 mg/kg) or allopregnanolone (0, 3.0, 10.0 mg/kg) in an injection volume of 1 mL/100 250 
grams of body weight.  Allopregnanolone (3α-hydroxy-5α-pregnan-20-one; Steraloids, Inc.) was 251 
dissolved in a vehicle of 20% (2-hydroxypropyl)-β-cyclodextrin (Sigma-Aldrich) and midazolam 252 
HCl (Sigma-Aldrich) was dissolved in 0.9% NaCl vehicle.  EtOH-naïve (Naïve) and EtOH-253 
withdrawn (WD) mutant and WT mice received drug doses in a randomized order according to a 254 
mixed, factorial design; each mouse was tested six times for social approach following injection 255 
of vehicle and doses of allopregnanolone (ALLO) and midazolam (MDZ).  Stable levels of 256 
drinking were maintained throughout social approach testing from weeks eight to sixteen (Fig 257 
S5).  258 
 259 
Statistical analyses  260 
Ethanol intake (g/kg) data collected from DID experiments were analyzed using two-way 261 
repeated measures analyses of variance (2-way RM ANOVA; genotype x day).  For mice 262 
receiving continuous (CA) or intermittent access (IA) to alcohol, individual mean intake (g/kg) 263 
and percent ethanol intake data for 18 ethanol-access days were analyzed by 2-way ANOVA to 264 
detect interactions between protocol and genotype.  To identify genotype-associated differences 265 
in the progression of IA or CA drinking, 2-way RM ANOVA (genotype x week) were also run 266 
on individual daily intake (g/kg) and alcohol preference values averaged by week. 267 
For all significant 2-way ANOVA, Dunnett’s test was used to compare treatment levels 268 
to a control condition (for DID, CA, IA drinking experiments: wild type x mutant; for social 269 
approach and locomotion in withdrawal: wild type x mutant, vehicle x drug dose; for ascending 270 
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concentrations of EtOH: 10% EtOH x all other concentrations, wild type x mutant; for sucrose or 271 
quinine concentrations: lowest concentration x all other concentrations, wild-type x mutant).   272 
 273 
Results 274 
Escalated binge-like drinking by H101R mutants 275 
Gabra2 H101R mutant mice escalated their four-hour binge-like drinking compared to 276 
wild-types in the drinking in the dark (DID) protocol (Fig 1A, 1B). Two-way RM ANOVA 277 
(genotype x day) of EtOH intake (g/kg/2 or 4hr) revealed main effects of genotype 278 
(F(3,102)=77.67, p<0.001) and day (F(3, 34)=13.32, p<0.001). Compared with their two-hour 279 
access intake, mice consumed significantly more when they received four-hour access to EtOH 280 
on the final day of the DID protocol.   281 
In separate mice, four-hour DID licking data were collected using a lickometer setup and 282 
analyzed in ten-minute time bins (Fig S4). Two-way RM ANOVA (time bin x genotype) 283 
identified a main effect of time bin (F(24, 600)=7.144, p<0.001) with the greatest number of 284 
licks occurring in the first ten-minutes of EtOH access.  Two-way ANOVA of EtOH intake data 285 
in the lickometer setup identified an interaction between genotype and day (F(9,66)=2.28, 286 
p=0.027) driven by increased drinking by H101R mice compared to wild-types on the binge day 287 
(Fig 1B), but not on prior, two-hour access days (data not shown).  Although a significant time 288 
bin x genotype interaction was not apparent upon analyzing the four-hour licking data, only 289 
wild-type mice appeared to show a dip in licking at the two-hour time point when EtOH would 290 
have been removed on the preceding days (Fig S4).   291 
Blood was collected from wild-type and mutant mice assigned to single-bottle DID 292 
experiments. A one-way ANOVA of BEC (mg/dL) by genotype revealed a non-significant trend 293 
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(p=0.062) of reduced BECs in Q241M mutants (M=73.93±12.3) and slightly higher than average 294 
BECs in H101R mutants (M=127.43±18.72) as compared to wild-types (Fig 1C). With the 295 
exception of Q241M mutants, all genotypes satisfied the requirement of >80 mg/dL for binge-296 
like drinking.  A simple linear regression equation (BEC = 52.3+0.136*(licks within final hour)) 297 
was able to predict significant variability in BEC values according to the number of licks within 298 
the final hour of four-hour binge-like drinking (F(1,28) =12.01, p=0.002; R2 = 0.3).  299 
Two-way ANOVA (genotype x DID protocol) detected a significant interaction (F(1, 300 
32)=9.53, p=0.004). H101R mutants in the original, single-bottle DID experiment consumed 301 
more EtOH (g/kg) as compared to those assessed for two-bottle choice DID; in contrast, WT 302 
mice consumed similar amounts regardless of DID protocol (Fig S3).   In contrast with the 303 
original DID protocol findings, there was no significant difference in 4-hour binge intake (g/kg) 304 
between WT and H101R mice that were evaluated in a two-bottle choice DID protocol. Despite 305 
consuming comparable g/kg EtOH, H101R mice had a significantly higher alcohol preference 306 
(%) as compared to WT controls (1-way ANOVA; (F(1, 15)=6.32, p=0.024); WT: 307 
M=84.30±6.53; H101R: M=57.81±8.04). High preference for alcohol was driven by low water 308 
consumption by H101R mice and contributed to significantly lower total fluid intake by these 309 
mutants (1-way ANOVA; (F(1,15)=6.20, p=0.025)).  310 
 311 
 312 
Reduced chronic ethanol intake by Q241M mutants 313 
Mice that received intermittent rather than continuous access to alcohol consumed 314 
significantly greater amounts of ethanol (F(1, 68)=157.9, p<0.001; Fig 1D, 1E).   Two-way 315 
ANOVA also detected a significant main effect of genotype on EtOH intake (F(3, 68)=24.16, 316 
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p<0.001); compared to WT mice, Gabra2 Q241M mutants consumed less 20% EtOH while 317 
S270H/L277A mutants consumed more 20% EtOH (Fig 1D).    318 
Daily individual EtOH intake values (g/kg) were averaged by week for mice with 319 
intermittent access to EtOH. Two-way RM ANOVA of these data revealed a significant 320 
genotype by week interaction (F(15, 185)=2.13, p=0.01), and main effects of genotype (F(3, 321 
37)=33.27, p<0.001) and week (F(5, 185)=9.15, p<0.001).  While wild-type mice consistently 322 
consumed more EtOH than Q241M mutants, both wild-type and Q241M mice consumed 323 
progressively more EtOH per day for the first three weeks (Fig 2A).  EtOH intake values 324 
stabilized for all genotypes following the third week of intermittent access.  Similarly, Q241M 325 
mutants consumed less EtOH than wild-types in the continuous access experiment, driving a 326 
main effect of genotype (F(3, 31)=9.94, p<0.001; Fig 2B).  In contrast with mice that received 327 
intermittent access to alcohol, those with continuous access reduced their drinking, generating 328 
significantly lower intake values following the second week of drinking (main effect of week: 329 
(F(5, 155)=5.72, p<0.001; Fig 2B).  Therefore, it appears that, regardless of the drinking 330 
protocol, mice require 9-14 days of alcohol access for their daily EtOH intake (g/kg) to stabilize. 331 
Two-way RM ANOVA on average total daily volume intake (mL water + mL EtOH) values 332 
revealed no effect of genotype (Wt vs. mutant genotypes) or of chronic alcohol access protocol 333 
(continuous vs. intermittent). 334 
Daily drinking data were also analyzed as % EtOH preference (calculated as: mL EtOH 335 
intake/mL total fluid intake * 100).  For mice with intermittent EtOH access, 2-way RM 336 
ANOVA detected significant main effects of genotype (F(3, 37)=8.33, p<0.001) and week (F(5, 337 
185)=5.15, p<0.001) on % EtOH preference.  As revealed by post-hoc analyses, Q241M mice 338 
had significantly lower preference for EtOH as compared to wild-types, and, for all genotypes, 339 
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average daily % EtOH preference stabilized following the third week of intermittent access (Fig 340 
2C).  Analysis of continuous access % EtOH preference data identified main effects of genotype 341 
(F(3, 31)=3.39, p=0.03) and week (F(5, 155)=2.96, p=0.014).  The main effect of genotype was 342 
driven by a difference between the Q241M and S270H/L277A mutants; yet, no mutant line 343 
differed appreciably from wild-type controls. As seen with g/kg intake data from mice given 344 
continuous access to alcohol, % EtOH preference stabilized during the third week of continuous 345 
access drinking (Fig 2D).   346 
 347 
Social approach in forced alcohol abstinence 348 
On the first day of social approach testing, EtOH-withdrawing mice and EtOH-naïve 349 
controls received either 0.9% saline vehicle or 20% β-cyclodextrin vehicle.  These social 350 
approach data were analyzed within genotype by two-way ANOVA (EtOH-withdrawing vs. 351 
EtOH-naïve; saline vs. 20% BCD vehicle on the first day) to establish whether withdrawing mice 352 
exhibited deficits in social approach as compared to their ethanol-naïve counterparts.  This 353 
analysis revealed that wild-type mice in forced abstinence spent significantly less time in the 354 
social approach zone as compared to EtOH-naïve wild-type controls (F(1, 16)=14.347, p=0.002; 355 
Fig 3).  Likewise, H101R mutants that were in forced abstinence from alcohol spent significantly 356 
less time in the social approach zone compared to mice with no history of EtOH consumption  357 
(F(1, 15)=9.164, p=0.008; Fig 3).   358 
Conversely, there was no difference in social approach behavior between Q241M or 359 
S270H/L277A mutants in forced abstinence and their EtOH-naïve counterparts (Fig 3). These 360 
initial analyses guided subsequent treatments with midazolam and allopregnanolone to reverse 361 
withdrawal-associated social deficits observed in WT and H101R mice.   Since two-way 362 
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ANOVA did not reveal any differences between social approach duration or distance travelled 363 
data according to vehicle (0.9% saline vs. 20% β-cyclodextrin) for any genotype, individual 364 
vehicle averages were used for data portrayal (Fig 4 and Fig S6).  365 
 Because six-week intermittent access drinking differed by genotype and was predicted to 366 
impact behavior in withdrawal, social approach was analyzed with one-way RM ANOVA by 367 
genotype. Social approach after midazolam or allopregnanolone treatment was compared to 368 
behavior after 0.9% saline or 20% β-cyclodextrin administration, respectively.   These analyses 369 
revealed significant treatment effects in wild-type mice with the 0.56 and 1.0 mg/kg doses of 370 
midazolam and the 3.0 and 10.0 mg/kg doses of allopregnanolone increasing social approach in 371 
withdrawal as compared to their respective vehicles  (MDZ: (F(2, 18)=8.241, p=0.003); ALLO:  372 
(F(2, 18)=5.22, p=0.016); Fig 4A). For H101R mice, there was a significant effect of midazolam 373 
(F(2, 16)=6.403, p=0.009) with both doses reducing social approach time, which is likely due to 374 
sedation (Fig 4B, 4D). Since the data were not normally distributed, Friedman RM ANOVA on 375 
ranks was conducted on allopregnanolone data for H101R mice to reveal a significant effect of 376 
the drug treatment (χ2(2)=13.56, p=0.001).  As compared to 20% β-cyclodextrin vehicle, both the 377 
3.0 and 10.0 mg/kg doses of allopregnanolone increased social approach in withdrawal from 378 
alcohol (Fig 4B).  379 
 Distance travelled during social approach testing in withdrawal was used as a potential 380 
metric of withdrawal-induced motor impairments (Knapp et al. 2005) and for allopregnanolone- 381 
or midazolam-induced sedation.  None of the genotypes showed motor impairment due to 382 
withdrawal as revealed by one-way ANOVA between same-genotype EtOH-naïve and EtOH-383 
withdrawn mice. This suggests that the social approach protocol used in the present study 384 
allowed for independent measurements of social avoidance and locomotor behavior. Additional 385 
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one-way RM ANOVA or Friedman RM ANOVA were run within genotype to detect drug-386 
treatment effects on motor activity during withdrawal. There was no effect of drug treatment on 387 
locomotor behavior in wild-type mice in withdrawal (Fig 4C). However one-way RM ANOVA 388 
did detect a significant effect of treatment in H101R mutants (F(2, 16)=14.771, p<0.001) with 389 
reduced distance travelled following treatment with either dose of midazolam (0.56 or 1.0 390 
mg/kg; Fig 4D).  This suggests that reduced social approach at this dose was associated with 391 
increased sedation. 392 
To establish whether there was an effect of genotype on social approach, a one-way 393 
ANOVA was conducted on data collected from EtOH-naïve, vehicle-treated mice. Q241M mice 394 
showed a trend toward reduced social approach compared to wild-type animals.  Thus, EtOH-395 
naïve wild-type and EtOH-naïve Q241M mice were included in subsequent social approach tests 396 
following midazolam and allopregnanolone administration to determine whether anxiolytic 397 
compounds could recover social approach by Q241M mutants.   398 
 Two-way RM ANOVA on social approach by EtOH-naïve Q241M and wild-type mice 399 
treated with midazolam revealed a significant effect of drug treatment (F(2, 36)=4.88, p=0.013) 400 
and an interaction between genotype and drug administration  (F(2, 36)=4.75, p=0.015). 401 
Midazolam (1.0 mg/kg) treatment increased social approach time by EtOH-naïve Q241M mice 402 
to levels that were comparable to EtOH-naïve wild-type controls (Fig S6A, S6B). Conversely, 403 
there was no effect of allopregnanolone treatment or genotype on approach behavior.   404 
Midazolam treatment interacted with genotype (F(2,36)=4.12, p=0.025), producing a significant 405 
reduction in distance travelled by EtOH-naïve wild-type mice, but not by Q241M mutants (Fig 406 
S6C, S6D).  Allopregnanolone treatment also interacted with genotype (F(2,36)=10.584, 407 
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p<0.001); however, this interaction was driven by increased distance travelled by wild-type mice 408 
and reduced locomotion by Q241M mutants (Fig S6C, S6D).   409 
 The significant difference between ethanol intake (g/kg) by wild-type and Q241M mice 410 
remained consistent throughout the sixteen weeks of intermittent alcohol drinking (F(3, 37) = 411 
22.22, p<0.001); drug administration and social approach testing beginning in week eight did not 412 
impact ethanol consumption by any genotype (Fig S5). 413 
 414 
Concentration-dependent ethanol, sucrose or quinine preference 415 
Two-way RM ANOVA was used to detect an interaction between genotype and either 416 
intake or percent preference for a specific concentration of ethanol. Analysis of intake data 417 
(g/kg) revealed a significant interaction (F(9,96)=11.28, p<0.001) and a main effect of 418 
concentration (F(3, 96)=102.31, p<0.001).  Post-hoc comparisons were conducted as 10% vs. 3, 419 
6, or 20% EtOH (w/v).  All genotypes consumed more 10% EtOH (w/v) as compared to the 3% 420 
solution while only the H101R and S270H/L277A mutants consumed more 20% than the 10% 421 
concentration. Conversely, Q241M mice drank considerably less 20% EtOH (Fig 5). As 422 
compared with wild-types, H101R mice consumed significantly more 20% EtOH while Q241M 423 
mutants consumed significantly less 20% EtOH (Fig 5).  Two-way RM ANOVA of % EtOH 424 
preference data detected a significant effect of EtOH concentration (F(3,96)=82.77, p<0.001) 425 
which was due to reduced preference for the 20% EtOH (w/v) solution regardless of genotype 426 
(Fig 5).  Two-way RM ANOVA on total daily fluid intake (mL EtOH + mL H2O) revealed a 427 
significant main effect of concentration (F(3, 96)=40.89, p<0.001) and an interaction between 428 
genotype and EtOH concentration (F(9,96) = 4.535, p<0.001). All mice consumed the most total 429 
fluid upon receiving access to 3% EtOH and water; however, only Q241M mice did not show 430 
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increased total volume intake when offered 20% EtOH and water. This suggests that mice may 431 
adjust their water intake based on their g/kg EtOH consumption; because 20% EtOH intake by 432 
Q241M mice was low, they did not increase their water intake like WT, H101R and 433 
S270H/L277A mutants.  434 
Two-way RM ANOVA was also used to determine if there was a significant interaction 435 
between genotype and preference for ascending concentrations of sucrose solution (10, 30, 100 436 
mM). A main effect of concentration (F(2, 42)=44.04, p<0.001; Fig S7) was  associated with 437 
preference for the 30 and 100 mM sucrose solutions as compared to the 10 mM sucrose 438 
concentration.  Two-way RM ANOVA revealed a main effect of quinine (F(1,20)=29.13, 439 
p<0.001) with all genotypes avoiding the high, 0.3 mM quinine solution  (Fig S7). Analysis of 440 
total daily fluid intake (mL sucrose solution + mL water) revealed a main effect of sucrose 441 
concentration (F(2, 42)=69.98, p<0.001) resulting from greater volumetric intake when mice 442 
were given access to 100 mM sucrose and water. Interestingly, a similar effect was observed 443 
when mice received 0.3 mM quinine and water; all genotypes significantly increasing their total 444 
fluid intake (mL quinine solution + mL water; F(1, 20)=19.81, p<0.001).  While increased 445 
volumetric intake during sucrose testing was associated with substantial100 mM sucrose solution 446 
intake, the increase in fluid consumed when mice received access to 0.3 mM quinine was driven 447 
by elevated water consumption.  448 
 449 
Discussion 450 
The present study highlights the following findings: mutant mice with BZD-insensitive 451 
α2-containing GABAA receptors escalated their binge-like alcohol intake; conversely, chronic 452 
intermittent drinking by H101R mutants was indistinguishable from wild-type mice.  Rendered 453 
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insensitive to ALLO and THDOC at α2-containing GABAA receptors, Q241M mutants 454 
consumed less than wild-types in the chronic dependence-inducing and moderate drinking 455 
protocols.  Finally, mice harboring the S270H/L277A mutations in the Gabra2 protein sequence 456 
consumed the same amount of alcohol as wild-type mice; yet, unlike wild-type mice, these 457 
mutants did not show disrupted social approach in withdrawal from chronic, excessive alcohol 458 
intake.  459 
Human and rodent studies have revealed a correlation between reduced GABAA receptor 460 
BZD-binding sites and alcohol-dependence (Freund 1980; Freund and Ballinger 1988; Volkow 461 
et al., 1993, 1995; Gilman et al., 1996; Lingford-Hughes et al., 1998; Laukkanen et al., 2013; but 462 
Korpi et al., 1992).  By evaluating H101R mutant mice, we provide evidence to suggest that 463 
BZD-insensitivity - or a yet unknown functional change caused by the mutation - can promote 464 
excessive binge-like alcohol consumption when mice are not given the choice between ethanol 465 
and water. In a two-bottle choice drinking in the dark procedure (2BC DID), H101R mutants 466 
maintained wild-type-like levels of EtOH consumption; these values were significantly lower 467 
than those achieved by H101R mutants with access to EtOH only.  In contrast with wild-types, 468 
2BC did not elicit equal volumetric EtOH and water drinking by H101R mutant mice (EtOH 469 
preference means; H101R: 84.3%; WT: 57.81%). Interestingly, this disparity was not observed 470 
in chronic 2BC protocols despite similar EtOH (g/kg) intake between H101R and wild-type 471 
mice. These findings may indicate that, in H101R mutants, the presentation of a non-EtOH-472 
containing bottle is sufficient to diminish limited-access drinking. It is possible that single-bottle 473 
access to EtOH may drive compulsive intake and that providing an alternative is sufficient to 474 
disrupt escalated drinking. Future lickometer assessments will see if presentation of a second 475 
bottle disrupts the pattern of licking during the four-hour DID access period. In addition, work 476 
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should address how other environmental enrichments may disrupt single-bottle EtOH drinking 477 
and whether this effect is specific to H101R mutants.     478 
To clarify the present findings, future work must establish how α2(H101R)-containing 479 
GABAA receptors respond to ethanol.  In recombinant receptors, the α2(H101R) mutation 480 
produces a rightward shift of the GABA dose-response curve (Benson et al.,1998), which might 481 
suggest a reduced sensitivity to GABA in vivo.  However, at least in central and 482 
lateral/basolateral amygdala, the amplitudes of extracellularly evoked inhibitory postsynaptic 483 
currents are unchanged by the α2(H101R) mutation, which is consistent with no change in 484 
GABAergic functions in the absence of benzodiazepines (Marowsky et al. 2004). Until we have 485 
a more complete understanding of how the α2(H101R) mutation alters the properties of GABAA 486 
receptors throughout the brain, we cannot formally exclude the possibility that increased binge-487 
like drinking by H101R mutants may reflect altered GABA sensitivity and/or potentiation of 488 
GABA-induced currents by ethanol. 489 
Animals rendered selectively insensitive to ALLO and THDOC at α2-containing GABAA 490 
receptors reduced their drinking in a protocol that models dependence-inducing ethanol intake.  491 
The Q241M mutation impedes neurosteroid positive modulator binding to the membrane-bound 492 
modulatory site of the α2-subunit (Hosie et al., 2006).  Because both low-concentration 493 
potentiation and activation by high concentrations of neurosteroids require this modulatory site, 494 
these mutants should be insensitive to all neurosteroid action at α2-containing GABAA receptors.  495 
Indeed, in vitro dose-effect curves do show that this single amino acid substitution can block 496 
ALLO-potentiation of GABA currents (Hosie et al., 2009). A number of studies demonstrate that 497 
ALLO or its synthetic analog, ganaxolone, can increase responding for alcohol and can escalate 498 
alcohol intake (Janak and Gill 2003; Nie and Janak 2003; Ramaker et al., 2014).  Yet, studies 499 
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also provide evidence for reduced drinking with regional increases in ALLO or following ALLO 500 
or ganaxolone treatment (Besheer et al., 2010; Cook et al., 2014; Ramaker et al., 2015); 501 
conflicting evidence may reflect dose- and time-dependent effects of ALLO and/or an interaction 502 
between ALLO and history of alcohol consumption (Janak et al., 1998; Ford et al., 2005; 503 
Ramaker et al., 2011).  In the present investigation, Q241M mutants showed reduced alcohol 504 
intake beginning with their first day of access, indicating that neurosteroids may need to act on 505 
α2-containing GABAA receptors for alcohol to have its rewarding effects.  One hypothesis is that 506 
ALLO or THDOC initially binds to the membrane-bound GABAA receptor modulatory site to 507 
induce a conformational change in the receptor. This may subsequently render an extracellular 508 
site more accessible to ethanol, leading to receptor positive modulation.  Additional studies need 509 
to establish whether or not α2(Q241M)-containing receptors are sensitive to ethanol-potentiation 510 
of GABA-induced currents. The possibility that ethanol reward value may be altered in Q241M 511 
mutants must be addressed directly in studies comparing alcohol-reinforced responding by 512 
mutants to responding by wild-type controls.  513 
During a chronic intermittent access to alcohol procedure, wild-type, H101R, and 514 
S270H/L277A mice all consumed ~20 g/kg/24 hr for six weeks. Despite consistently drinking 515 
substantial amounts of alcohol, S270H/L277A mutants did not show wild-type-like deficits in 516 
social behavior during withdrawal from alcohol.   These mutants harbor two mutations, one to 517 
block potentiation by ethanol and the other is a gain-of-function mutation that normalizes GABA 518 
sensitivity (Homanics et al., 2005; Borghese et al., 2006b).  To identify the specific substitution 519 
that affects behavior in withdrawal, it would be necessary to pair the S270H mutation with an 520 
alternative gain-of-function mutation; if these mutants were to behave like the present 521 
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S270H/L277A mice, then withdrawal-like symptoms may specifically involve serine at location 522 
270 in the α2-subunit protein sequence.   523 
In agreement with earlier work, the present findings demonstrate similar binge-like 524 
ethanol intake by mutant male S270H/L277A and wild-type mice (Blednov et al. 2011). 525 
However, drinking by S270H/L277A mutants may exceed that of wild-types when animals 526 
receive intermittent access to a high concentration of ethanol (i.e. 20% EtOH (w/v); this 527 
difference is not evident when animals receive 15% EtOH (v/v; Blednov et al. 2011).  528 
S270H/L277A mutants may be less sensitive to some of the aversive effects of alcohol as 529 
supported by their escalated chronic ethanol consumption, insensitivity to conditioned taste 530 
aversion (Blednov et al. 2011) and intact social approach behavior in withdrawal from chronic 531 
alcohol. Future studies need to clarify whether these mice are selectively insensitive to the 532 
aversive effects of ethanol or if they also show deficits in their sensitivity to reward.  533 
High-risk alcohol dependence–associated GABRA2 allelic variants do not affect primary 534 
protein sequence in humans, and therefore, mutant mice with amino acid substitutions do not 535 
serve as humanized preclinical models to assess alcohol dependence risk.  The present study 536 
does, however, provide insight regarding how alcohol or endogenous ligands may interact with 537 
the GABAA receptor α2-subunit protein to either increase or reduce drinking.  Because previous 538 
studies using Gabra2 null mutants did not reveal any differences in ethanol intake (Dixon et al., 539 
2012), we chose to use mice harboring targeted amino acid substitutions to address the role of 540 
precise GABAA receptor modulatory sites in consumption.  Although the action of alcohol on 541 
these mutated receptors is not fully characterized, we speculate that α2-containing GABAA 542 
receptor sensitivity to benzodiazepines, neurosteroids, or another presently unidentified 543 
endogenous ligand may influence specific patterns of drinking.  To determine if the present 544 
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preclinical findings translate to alcohol-dependent patients, clinical studies should investigate 545 
individuals with the high-risk GABRA2 haplotype for their sensitivity to benzodiazepines, 546 
allopregnanolone and THDOC. Interestingly, recent clinical findings suggest that high AUD-risk 547 
GABRA2 SNPs may occur in spans of sequence that regulate GABAA receptor gene expression 548 
during a specific perinatal period (Lieberman et al., 2015). Altered expression of receptor 549 
subunits during development may change GABAA receptor composition and sensitivity to 550 
endogenous modulators. Future research addressing the potential regulatory role of AUD-551 
associated GABRA2 SNPs may guide the development of pharmacogenetic tools to aid in the 552 
diagnosis and treatment of alcohol use disorders. 553 
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Table 1       
Experimental group ns 
  
WT H101R Q241M 
S270H/    
L277A  
DID n =10 9 9 10 
DID with lickometer n =5 5 9 8 
2-bottle choice DID n =9 8 - - 
Intermittent Access 
(IA) 
n = 11 10 10 10 
IA social approach n = 10 9 10 10 
EtOH-naïve  
social approach            
n = 9 11 9 11 
Continuous Access n = 9 8 9 9 
Ascending 
concentrations of 
EtOH (3-20%) 
n = 8 9 9 10 
Ascending 
concentrations of  
sucrose or quinine 
n =8 4 5 7-8
&
 
& 
One mouse euthanized following sucrose testing  
 
 
